Procter & Gamble (PG)
(Delayed Data from NYSE)
$166.03 USD
-1.68 (-1.00%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $166.68 +0.65 (0.39%) 7:14 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$166.03 USD
-1.68 (-1.00%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $166.68 +0.65 (0.39%) 7:14 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Zacks News
Is Fidelity High Dividend ETF (FDVV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FDVV
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
FedEx and Charles Schwab have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
FedEx and Charles Schwab have been highlighted as Zacks Bull and Bear of the Day.
These 3 Companies Have Recently Provided Upbeat Guidance
by Derek Lewis
So far, consumers have had little issue forking up extra cash for these companies' products, helping to deliver better-than-expected quarterly results. Will pricing power run out?
Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Company News for Apr 24, 2023
by Zacks Equity Research
Companies in The News Are: PG, HCA, RF, ALB.
Procter & Gamble (PG) Shares Up on Earnings: ETFs in Focus
by Sanghamitra Saha
Procter & Gamble beats overall. These consumer staples ETFs benefited a lot from the earnings results.
Beat the Market Like Zacks: NVIDIA, Clorox, Procter & Gamble in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Earnings Data Deluge This Week
by Zacks Equity Research
Earnings Data Deluge This Week.
P&G Outperforms in Fiscal Q3; Flash PMI Numbers Later
by Mark Vickery
P&G stock has now swung to positive for the year on +2.3% gains in early trading today.
Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results benefit from robust pricing and a favorable mix, along with strength across its segments.
Procter & Gamble (PG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 3.79% and 4.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Econ Data, Q1 Earnings: Drip, Drip, Drip; CSX Beats
by Mark Vickery
Myriad economic and earnings releases may accumulate into something more meaningful ahead of the Fed's next policy meeting.
Procter & Gamble (PG) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Procter & Gamble's (PG) Q3 results are expected to reflect gains from improved productivity, business investments, cost productivity initiatives and strong demand trends, offset by higher costs.
Q1 Earnings Season Kicks Off Better than Expected
by Mark Vickery
We've got a long way to go, but some key regional banks have already reported and offered some relief to market participants.
Stocks Take a Breather as Inflation Rate of Change Continues to Slow
by Mayur Thaker
All eyes now shift to Q1 earnings and management commentary on forward guidance.
3 Critical Earnings Reports to Watch This Week
by Ethan Feller
These stocks cover three different, but important sectors of the economy
Procter & Gamble (PG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $151.77, marking a +0.46% move from the previous day.
Procter & Gamble (PG) Rewards Investors With 3% Dividend Hike
by Zacks Equity Research
Procter & Gamble's (PG) commitment to boost shareholder's value is backed by strong financial footing. The company hikes dividend by 3%.
3 Sector ETFs to Play as Recession Fears Are on the Rise
by Yashwardhan Jain
With recession fears on the rise, look into some sectors that can shield from market volatility.
The Zacks Analyst Blog Highlights The Procter & Gamble, PepsiCo, Bank of America, Medtronic and Blackstone
by Zacks Equity Research
The Procter & Gamble, PepsiCo, Bank of America, Medtronic and Blackstone are part of the Zacks Top Analyst Blog.
Top Research Reports for Procter & Gamble, PepsiCo & Bank of America
by Mark Vickery
Today's Research Daily features new research reports on 15 major stocks, including The Procter & Gamble Company (PG), PepsiCo, Inc. (PEP) and Bank of America Corporation (BAC).
Procter & Gamble (PG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $151.26 in the latest trading session, marking a +0.69% move from the prior day.
Brokers Suggest Investing in P&G (PG): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?